Erratum: PI4KIIIβ is a therapeutic target in chromosome 1q-amplified lung adenocarcinoma (Science Translational Medicine DOI: 10.1016/j.bbcan.2016.06.002)

X. Tan, P. Banerjee, A. Pha E, F. U.N. Rutaganira, K. Basu, N. Bota-Rabassedas, H. F. Guo, C. L. Grzeskowiak, X. Liu, J. Yu, L. Shi, D. H. Peng, B. L. Rodriguez, J. Zhang, V. Zheng, D. Y. Duose, L. M. Solis, B. Mino, M. G. Raso, C. BehrensI. I. Wistuba, K. L. Scott, M. Smith, K. Nguyen, G. Lam, I. Choong, A. Mazumdar, J. L. Hill, D. L. Gibbons, P. H. Brown, W. K. Russell, K. Shokat, C. J. Creighton, J. S. Glenn, J. M. Kurie

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Erratum: PI4KIIIβ is a therapeutic target in chromosome 1q-amplified lung adenocarcinoma (Science Translational Medicine DOI: 10.1016/j.bbcan.2016.06.002)'. Together they form a unique fingerprint.

Medicine & Life Sciences